摘要
2015231 Clinical observations of lenalidomide combination chemotherapy for relapsing or refractory multiple myeloma.LI Xin(李新),et al.Dept Hematol,Beijing Chaoyang Hosp,Capital Med Univ,Beijing100043.Natl Med J China 2015;95(10):745-748.Objective To explore the clinical efficacies and toxicities of lenalidomide combination chemotherapy in the treatment of relapsing or refractory multiple myeloma(MM)patients.Methods A total of 14 MM
